J F Riou - JoVE Visualize

Showing results (31-40 of 103) with videos related to

Pageof 11

Sort By:

Pathologie-Biologie|November 1, 1987

[Study, at the gene level, of the activation of topoisomerase II by antitumor agents]M J Vilarem, J F Riou, G Riou, et al.

Biochemical Pharmacology|December 15, 1986

Characterization of the topoisomerase II-induced cleavage sites in the c-myc proto-oncogene. In vitro stimulation by the antitumoral intercalating drug mAMSAJ F Riou, M J Vilarem, C J Larsen, et al.

Biochemistry|April 8, 1986

Purification and characterization of Plasmodium berghei DNA topoisomerases I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavageJ F Riou, M Gabillot, M Philippe, et al.

Biochemistry|June 4, 1998

Modulation in kinetics of lactone ring hydrolysis of camptothecins upon interaction with topoisomerase I cleavage sites on DNAI Chourpa, J F Riou, J M Millot, et al.

Mechanisms of Development|July 27, 2001

Cloning and developmental expression of STAT5 in Xenopus laevisA Pascal, J F Riou, C Carron, et al.

Seminars in Oncology|February 1, 1996

Preclinical evaluation of CPT-11 and its active metabolite SN-38F Lavelle, M C Bissery, S André, et al.

Biochimica Et Biophysica Acta|March 15, 1997

Structure-activity relation in camptothecin antitumor drugs: why a detailed molecular characterisation of their lactone and carboxylate forms by Raman and SERS spectroscopies?I Chourpa, A Beljebbar, G D Sockalingum, et al.

International Journal of Oncology|March 17, 2001

RPR-115135, a new non peptidomimetic farnesyltransferase inhibitor, induces G0/G1 arrest only in serum starved cellsP Russo, C Ottoboni, A Crippa, et al.

Biochemical Pharmacology|July 1, 1989

Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417E Multon, J F Riou, D LeFevre, et al.

Anti-Cancer Drug Design|August 14, 1998

Synthesis, DNA binding, topoisomerase II inhibition and cytotoxicity of two guanidine-containing anthracene-9,10-dionesS Routier, J L Bernier, J P Catteau, et al.

Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:

Pageof 11

Pathologie-Biologie|November 1, 1987

[Study, at the gene level, of the activation of topoisomerase II by antitumor agents]M J Vilarem, J F Riou, G Riou, et al.

Biochemical Pharmacology|December 15, 1986

Characterization of the topoisomerase II-induced cleavage sites in the c-myc proto-oncogene. In vitro stimulation by the antitumoral intercalating drug mAMSAJ F Riou, M J Vilarem, C J Larsen, et al.

Biochemistry|April 8, 1986

Purification and characterization of Plasmodium berghei DNA topoisomerases I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavageJ F Riou, M Gabillot, M Philippe, et al.

Biochemistry|June 4, 1998

Modulation in kinetics of lactone ring hydrolysis of camptothecins upon interaction with topoisomerase I cleavage sites on DNAI Chourpa, J F Riou, J M Millot, et al.

Mechanisms of Development|July 27, 2001

Cloning and developmental expression of STAT5 in Xenopus laevisA Pascal, J F Riou, C Carron, et al.

Seminars in Oncology|February 1, 1996

Preclinical evaluation of CPT-11 and its active metabolite SN-38F Lavelle, M C Bissery, S André, et al.

Biochimica Et Biophysica Acta|March 15, 1997

Structure-activity relation in camptothecin antitumor drugs: why a detailed molecular characterisation of their lactone and carboxylate forms by Raman and SERS spectroscopies?I Chourpa, A Beljebbar, G D Sockalingum, et al.

International Journal of Oncology|March 17, 2001

RPR-115135, a new non peptidomimetic farnesyltransferase inhibitor, induces G0/G1 arrest only in serum starved cellsP Russo, C Ottoboni, A Crippa, et al.

Biochemical Pharmacology|July 1, 1989

Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417E Multon, J F Riou, D LeFevre, et al.

Anti-Cancer Drug Design|August 14, 1998

Synthesis, DNA binding, topoisomerase II inhibition and cytotoxicity of two guanidine-containing anthracene-9,10-dionesS Routier, J L Bernier, J P Catteau, et al.

Pageof 11